Although the Biden Administration may be winning Americans’ approval for its battle against the coronavirus pandemic, drug abuse experts have expressed rising worry that federal efforts are lagging in the fight against a rising health menace: the resurgent opioid abuse and drug overdose crisis.
While overdoses for the first time might claim 100,000 U.S. lives in a single year, the national campaign to quell the opioid crisis, a top priority not that long ago, has become almost an “afterthought” for policy makers in Washington, D.C., the medical news site Stat reported:
“According to interviews with leading doctors, lobbyists, members of Congress, and multiple Biden Administration aides, proposed reforms include billions of new dollars for treatment and recovery services, a deregulation of addiction treatment medications, making many of 2020’s emergency telehealth allowances permanent, and scaling up harm-reduction offerings like needle exchanges, fentanyl test strips, and naloxone [an overdose antidote] distribution. But over a month into Biden’s presidency, it’s not clear when, or even if, a major push on addiction treatment will happen. Even if one does, it’s an open question whether it will lead to modest changes or the more radical approach some advocates say the crisis deserves.”